ACell logo

ACell

Developing and commercializing advanced extracellular matrix devices for effective tissue and organ repair across various surgical procedures.

VS
Kerecis logo

Kerecis

Kerecis is pioneering the use of fish skin and fatty-acids in the cellular therapy and regenerative medicine market.

Side-by-Side Comparison

Metric ACell Kerecis
Founded 1999 2011
Headquarters Not tracked yet Iceland
Employees 1001-5000 517
Industry Health Care, Manufacturing Health Care, Manufacturing, Medical Devices
Funding Stage Series Unknown Debt Financing
Total Funding $8.70M $210.77M
Funding Rounds 1 19
Business Model Not tracked yet Not tracked yet
Revenue Model Not tracked yet Not tracked yet
Services Not tracked yet Not tracked yet
Target Customers Not tracked yet Not tracked yet
Taxonomy Extracellular Matrix Devices, Tissue Repair, Organ Repair, Surgical Procedures, Regenerative Medicine, MatriStem Technology, Plastic Surgery, Wound Care, Regenerative Medicine Technology, General Surgery, Innovation Regenerative Medicine, Cellular Therapy, Wound Care, Burn Treatment, Surgical Procedures, Dental Applications, Omega-3, Fish-skin Technology, Tissue Regeneration, Startup, Investment, Healthcare Innovation, Biomedical Research
Website acell.com kerecis.com
ACell logo

About ACell

ACell is a company dedicated to the development and commercialization of advanced extracellular matrix devices used for effective tissue and organ repair during various surgical procedures. Founded in 1999, the company is headquartered in Columbia, Maryland, and operates a manufacturing facility in...

Kerecis logo

About Kerecis

Kerecis is a pioneering company in the cellular therapy and regenerative medicine market, using fish skin and fatty acids to revolutionize tissue healing. Founded in 2009 by Fertram Sigurjonsson, the company's patented technologies leverage fatty-acid rich products to enable tissue regeneration, min...

Frequently Asked Questions

ACell — Developing and commercializing advanced extracellular matrix devices for effective tissue and organ repair across various surgical procedures.. Kerecis — Kerecis is pioneering the use of fish skin and fatty-acids in the cellular therapy and regenerative medicine market.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ACell has raised $8.70M while Kerecis has raised $210.77M.
ACell and Kerecis operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Track both companies in real time

Signal Tracker monitors ACell, Kerecis, and millions of companies for 40+ signal types.

One analytics cookie (Google Analytics). Cookie Policy